Back to results
US 2021/0196659 A1Published application
Theraeutic agents for neurodegenerative diseases
AssigneeIntrabio Ltd.
InventorMallory FACTOR
Life of this patent
Estimating the term…
Abstract
The present disclosure provides for treating neurodegenerative diseases comprising administering leucine, acetyl-leucine or a pharmaceutically acceptable salt thereof.
Claims23
1-9. (canceled)
A method of treating restless legs syndrome (RLS) in a subject who has a neurodegenerative disease comprising:
- administering to the subject a therapeutically effective amount of leucine, acetyl-leucine, or a pharmaceutically acceptable salt thereof.
A method of treating restless legs syndrome (RLS) in a subject in need thereof, wherein the RLS is a neurodegenerative disease, the method comprising administering to the subject a therapeutically effective amount of leucine, acetyl-leucine, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.